Aquatic Capital Management LLC Has $2.54 Million Holdings in Revvity, Inc. (NYSE:RVTY)

Aquatic Capital Management LLC lifted its holdings in Revvity, Inc. (NYSE:RVTY - Free Report) by 589.2% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 22,745 shares of the company's stock after acquiring an additional 19,445 shares during the period. Aquatic Capital Management LLC's holdings in Revvity were worth $2,539,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. Victory Capital Management Inc. grew its holdings in shares of Revvity by 17.4% in the fourth quarter. Victory Capital Management Inc. now owns 70,250 shares of the company's stock valued at $7,841,000 after acquiring an additional 10,390 shares in the last quarter. JPMorgan Chase & Co. raised its holdings in shares of Revvity by 13.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 344,115 shares of the company's stock valued at $43,961,000 after acquiring an additional 41,497 shares in the last quarter. Contravisory Investment Management Inc. increased its holdings in shares of Revvity by 1,715.9% in the 4th quarter. Contravisory Investment Management Inc. now owns 69,186 shares of the company's stock worth $7,722,000 after buying an additional 65,376 shares during the last quarter. Janney Montgomery Scott LLC increased its stake in Revvity by 87.0% in the fourth quarter. Janney Montgomery Scott LLC now owns 7,891 shares of the company's stock valued at $881,000 after acquiring an additional 3,672 shares during the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. raised its holdings in shares of Revvity by 41.5% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 12,072 shares of the company's stock valued at $1,352,000 after buying an additional 3,542 shares in the last quarter. Institutional investors own 86.65% of the company's stock.

Revvity Stock Up 1.2 %

Shares of RVTY stock traded up $1.14 on Friday, reaching $94.04. 944,884 shares of the stock were exchanged, compared to its average volume of 931,013. The company has a current ratio of 3.60, a quick ratio of 3.03 and a debt-to-equity ratio of 0.41. Revvity, Inc. has a twelve month low of $88.53 and a twelve month high of $129.50. The company has a market capitalization of $11.30 billion, a price-to-earnings ratio of 42.55, a PEG ratio of 3.82 and a beta of 1.07. The business's 50 day moving average price is $102.80 and its 200 day moving average price is $112.02.

Revvity (NYSE:RVTY - Get Free Report) last announced its quarterly earnings results on Monday, April 28th. The company reported $1.01 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.96 by $0.05. The business had revenue of $664.76 million during the quarter, compared to the consensus estimate of $662.30 million. Revvity had a net margin of 9.81% and a return on equity of 7.68%. The business's revenue was up 2.3% compared to the same quarter last year. During the same quarter last year, the firm posted $0.98 EPS. As a group, sell-side analysts expect that Revvity, Inc. will post 4.94 earnings per share for the current fiscal year.

Revvity Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, August 8th. Stockholders of record on Friday, July 18th will be given a $0.07 dividend. The ex-dividend date of this dividend is Friday, July 18th. This represents a $0.28 annualized dividend and a dividend yield of 0.30%. Revvity's payout ratio is 11.91%.

Analyst Ratings Changes

Several equities analysts have recently commented on the stock. Barclays lowered their price objective on shares of Revvity from $140.00 to $110.00 and set an "overweight" rating for the company in a research note on Thursday, April 10th. KeyCorp boosted their price objective on shares of Revvity from $132.00 to $145.00 and gave the company an "overweight" rating in a report on Monday, February 3rd. JPMorgan Chase & Co. cut their price objective on shares of Revvity from $120.00 to $100.00 and set a "neutral" rating for the company in a research report on Tuesday, April 29th. Robert W. Baird dropped their price target on shares of Revvity from $127.00 to $125.00 and set an "outperform" rating for the company in a research report on Tuesday, April 29th. Finally, The Goldman Sachs Group lowered their price target on Revvity from $140.00 to $125.00 and set a "buy" rating on the stock in a report on Tuesday, April 29th. Four analysts have rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, Revvity presently has a consensus rating of "Moderate Buy" and an average target price of $125.64.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.